Diagnostic technologies for the Point-of-Care in the Developing World
Event details
| Date | 20.11.2013 |
| Hour | 12:15 › 13:15 |
| Speaker | Dr. Catherine Klapperich, Director of the Laboratory for Diagnostics and Global Healthcare Technologies, Boston University |
| Location | |
| Category | Conferences - Seminars |
In the framework of the EssentialTech Program, CODEV welcomes Dr. Klapperich, who will discuss how the field of molecular diagnostics can improve global healthcare in developing countries.
Her laboratory focuses on the design and engineering of manufacturable, disposable systems for use in low-resource settings at the point-of-care.
Innovative solutions have, for example been proposed to perform microfluidic sample preparation for bacterial and viral targets from several human body fluids. These technologies include nucleic acid extraction, protein extraction, microorganism enrichment and/or concentration and small-scale dialysis.
Dr. Klapperich's lab is currently working on devices for the detection and quantification of HIV, hemorrhagic fevers, infectious diarrheas, influenza, MRSA and cancer biomarkers. Current projects include detection by PCR, isothermal amplification, and novel optical techniques. The approach considers assay development, device design, sample flow, storage and transport all opportunities to drive down the cost and increase the accessibility of molecular tests in the developing world.
Her laboratory focuses on the design and engineering of manufacturable, disposable systems for use in low-resource settings at the point-of-care.
Innovative solutions have, for example been proposed to perform microfluidic sample preparation for bacterial and viral targets from several human body fluids. These technologies include nucleic acid extraction, protein extraction, microorganism enrichment and/or concentration and small-scale dialysis.
Dr. Klapperich's lab is currently working on devices for the detection and quantification of HIV, hemorrhagic fevers, infectious diarrheas, influenza, MRSA and cancer biomarkers. Current projects include detection by PCR, isothermal amplification, and novel optical techniques. The approach considers assay development, device design, sample flow, storage and transport all opportunities to drive down the cost and increase the accessibility of molecular tests in the developing world.
Practical information
- General public
- Free
- This event is internal